ID   CEPT1_HUMAN             Reviewed;         416 AA.
AC   Q9Y6K0; Q69YJ9; Q9P0Y8;
DT   29-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1999, sequence version 1.
DT   10-MAY-2017, entry version 135.
DE   RecName: Full=Choline/ethanolaminephosphotransferase 1;
DE            Short=hCEPT1;
DE            EC=2.7.8.1;
DE            EC=2.7.8.2;
GN   Name=CEPT1; ORFNames=PRO1101;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, ENZYME ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, COFACTOR, AND TISSUE SPECIFICITY.
RX   PubMed=10191259; DOI=10.1042/bj3390291;
RA   Henneberry A.L., McMaster C.R.;
RT   "Cloning and expression of a human
RT   choline/ethanolaminephosphotransferase: synthesis of
RT   phosphatidylcholine and phosphatidylethanolamine.";
RL   Biochem. J. 339:291-298(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Fetal liver;
RA   Zhang C., Yu Y., Zhang S., Zhou G., Wei H., Bi J., Xu W., Zai Y.,
RA   Feng F., Liu M., He F.;
RT   "Functional prediction of the coding sequences of 5 new genes deduced
RT   by analysis of cDNA clones from human fetal liver.";
RL   Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lymph, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-162.
RC   TISSUE=Bone marrow;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   FUNCTION.
RX   PubMed=10893425; DOI=10.1074/jbc.M005786200;
RA   Henneberry A.L., Wistow G., McMaster C.R.;
RT   "Cloning, genomic organization, and characterization of a human
RT   cholinephosphotransferase.";
RL   J. Biol. Chem. 275:29808-29815(2000).
RN   [7]
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=12216837; DOI=10.1007/s11745-002-0947-6;
RA   Wright M.M., McMaster C.R.;
RT   "PC and PE synthesis: mixed micellar analysis of the
RT   cholinephosphotransferase and ethanolaminephosphotransferase
RT   activities of human choline/ethanolamine phosphotransferase 1
RT   (CEPT1).";
RL   Lipids 37:663-672(2002).
RN   [8]
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF ASN-144; SER-146; GLY-156;
RP   THR-214; GLU-215; VAL-216; ILE-221; LEU-226 AND VAL-228.
RX   PubMed=12221122; DOI=10.1091/mbc.01-11-0540;
RA   Henneberry A.L., Wright M.M., McMaster C.R.;
RT   "The major sites of cellular phospholipid synthesis and molecular
RT   determinants of fatty acid and lipid head group specificity.";
RL   Mol. Biol. Cell 13:3148-3161(2002).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18 AND THR-40, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-40, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Catalyzes both phosphatidylcholine and
CC       phosphatidylethanolamine biosynthesis from CDP-choline and CDP-
CC       ethanolamine, respectively. Involved in protein-dependent process
CC       of phospholipid transport to distribute phosphatidyl choline to
CC       the lumenal surface. Has a higher cholinephosphotransferase
CC       activity than ethanolaminephosphotransferase activity.
CC       {ECO:0000269|PubMed:10191259, ECO:0000269|PubMed:10893425}.
CC   -!- CATALYTIC ACTIVITY: CDP-ethanolamine + 1,2-diacyl-sn-glycerol =
CC       CMP + a phosphatidylethanolamine. {ECO:0000269|PubMed:10191259}.
CC   -!- CATALYTIC ACTIVITY: CDP-choline + 1,2-diacyl-sn-glycerol = CMP + a
CC       phosphatidylcholine. {ECO:0000269|PubMed:10191259}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:10191259};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000269|PubMed:10191259};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=37 uM for CDP-choline {ECO:0000269|PubMed:10191259,
CC         ECO:0000269|PubMed:12216837};
CC         KM=101 uM for CDP-ethanolamine {ECO:0000269|PubMed:10191259,
CC         ECO:0000269|PubMed:12216837};
CC         Vmax=10.5 nmol/min/mg enzyme with CDP-choline as substrate
CC         {ECO:0000269|PubMed:10191259, ECO:0000269|PubMed:12216837};
CC         Vmax=4.35 nmol/min/mg enzyme with CDP-ethanolamine as substrate
CC         {ECO:0000269|PubMed:10191259, ECO:0000269|PubMed:12216837};
CC   -!- PATHWAY: Phospholipid metabolism; phosphatidylethanolamine
CC       biosynthesis; phosphatidylethanolamine from ethanolamine: step
CC       3/3.
CC   -!- PATHWAY: Phospholipid metabolism; phosphatidylcholine
CC       biosynthesis; phosphatidylcholine from phosphocholine: step 2/2.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:12221122}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:12221122}. Nucleus membrane
CC       {ECO:0000269|PubMed:12221122}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:12221122}.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:10191259}.
CC   -!- SIMILARITY: Belongs to the CDP-alcohol phosphatidyltransferase
CC       class-I family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF61194.1; Type=Frameshift; Positions=276; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF068302; AAD25170.1; -; mRNA.
DR   EMBL; AF138862; AAF61194.1; ALT_FRAME; mRNA.
DR   EMBL; AL355816; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC032610; AAH32610.1; -; mRNA.
DR   EMBL; BC049196; AAH49196.1; -; mRNA.
DR   EMBL; AL833102; CAH10403.1; -; mRNA.
DR   CCDS; CCDS830.1; -.
DR   RefSeq; NP_001007795.1; NM_001007794.2.
DR   RefSeq; NP_001317672.1; NM_001330743.1.
DR   RefSeq; NP_006081.1; NM_006090.4.
DR   UniGene; Hs.363572; -.
DR   UniGene; Hs.636850; -.
DR   ProteinModelPortal; Q9Y6K0; -.
DR   BioGrid; 115662; 29.
DR   IntAct; Q9Y6K0; 32.
DR   STRING; 9606.ENSP00000349696; -.
DR   DrugBank; DB00122; Choline.
DR   TCDB; 4.F.1.1.1; the choline/ethanolaminephosphotransferase 1 (cept1) family.
DR   iPTMnet; Q9Y6K0; -.
DR   PhosphoSitePlus; Q9Y6K0; -.
DR   SwissPalm; Q9Y6K0; -.
DR   BioMuta; CEPT1; -.
DR   DMDM; 74753524; -.
DR   EPD; Q9Y6K0; -.
DR   MaxQB; Q9Y6K0; -.
DR   PaxDb; Q9Y6K0; -.
DR   PeptideAtlas; Q9Y6K0; -.
DR   PRIDE; Q9Y6K0; -.
DR   DNASU; 10390; -.
DR   Ensembl; ENST00000357172; ENSP00000349696; ENSG00000134255.
DR   Ensembl; ENST00000545121; ENSP00000441980; ENSG00000134255.
DR   GeneID; 10390; -.
DR   KEGG; hsa:10390; -.
DR   UCSC; uc001eah.1; human.
DR   CTD; 10390; -.
DR   DisGeNET; 10390; -.
DR   GeneCards; CEPT1; -.
DR   HGNC; HGNC:24289; CEPT1.
DR   MIM; 616751; gene.
DR   neXtProt; NX_Q9Y6K0; -.
DR   OpenTargets; ENSG00000134255; -.
DR   PharmGKB; PA134892657; -.
DR   eggNOG; KOG2877; Eukaryota.
DR   eggNOG; COG5050; LUCA.
DR   GeneTree; ENSGT00530000063048; -.
DR   HOGENOM; HOG000034808; -.
DR   HOVERGEN; HBG107647; -.
DR   InParanoid; Q9Y6K0; -.
DR   KO; K13644; -.
DR   OMA; EYLVLWI; -.
DR   OrthoDB; EOG091G07XY; -.
DR   PhylomeDB; Q9Y6K0; -.
DR   TreeFam; TF313270; -.
DR   BioCyc; MetaCyc:HS05844-MONOMER; -.
DR   Reactome; R-HSA-1483191; Synthesis of PC.
DR   Reactome; R-HSA-1483213; Synthesis of PE.
DR   SABIO-RK; Q9Y6K0; -.
DR   UniPathway; UPA00558; UER00743.
DR   UniPathway; UPA00753; UER00740.
DR   GenomeRNAi; 10390; -.
DR   PRO; PR:Q9Y6K0; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000134255; -.
DR   CleanEx; HS_CEPT1; -.
DR   ExpressionAtlas; Q9Y6K0; baseline and differential.
DR   Genevisible; Q9Y6K0; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; TAS:ProtInc.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0004142; F:diacylglycerol cholinephosphotransferase activity; TAS:Reactome.
DR   GO; GO:0004307; F:ethanolaminephosphotransferase activity; TAS:Reactome.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006629; P:lipid metabolic process; TAS:ProtInc.
DR   GO; GO:0006656; P:phosphatidylcholine biosynthetic process; TAS:Reactome.
DR   GO; GO:0006646; P:phosphatidylethanolamine biosynthetic process; TAS:Reactome.
DR   InterPro; IPR000462; CDP-OH_P_trans.
DR   InterPro; IPR014472; CHOPT.
DR   PANTHER; PTHR10414; PTHR10414; 1.
DR   Pfam; PF01066; CDP-OH_P_transf; 1.
DR   PIRSF; PIRSF015665; CHOPT; 1.
DR   PROSITE; PS00379; CDP_ALCOHOL_P_TRANSF; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Endoplasmic reticulum; Glycoprotein;
KW   Lipid biosynthesis; Lipid metabolism; Magnesium; Manganese; Membrane;
KW   Metal-binding; Nucleus; Phospholipid biosynthesis;
KW   Phospholipid metabolism; Phosphoprotein; Reference proteome;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    416       Choline/ethanolaminephosphotransferase 1.
FT                                /FTId=PRO_0000289245.
FT   TRANSMEM     87    107       Helical. {ECO:0000255}.
FT   TRANSMEM    115    135       Helical. {ECO:0000255}.
FT   TRANSMEM    186    206       Helical. {ECO:0000255}.
FT   TRANSMEM    209    229       Helical. {ECO:0000255}.
FT   TRANSMEM    239    259       Helical. {ECO:0000255}.
FT   TRANSMEM    283    303       Helical. {ECO:0000255}.
FT   TRANSMEM    317    337       Helical. {ECO:0000255}.
FT   TRANSMEM    365    385       Helical. {ECO:0000255}.
FT   MOD_RES      18     18       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES      40     40       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:23186163}.
FT   CARBOHYD    144    144       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   MUTAGEN     138    138       K->M: Induces a reduction in both
FT                                cholinephosphotransferase and
FT                                ethanolaminephosphotransferase
FT                                activities.
FT   MUTAGEN     144    144       N->G: No effect.
FT                                {ECO:0000269|PubMed:12221122}.
FT   MUTAGEN     146    146       S->Q,C: No effect.
FT                                {ECO:0000269|PubMed:12221122}.
FT   MUTAGEN     156    156       G->C,S,A: Induces a reduction in
FT                                cholinephosphotransferase activity and
FT                                abolishes ethanolaminephosphotransferase
FT                                activity. {ECO:0000269|PubMed:12221122}.
FT   MUTAGEN     214    214       T->A: Alters the profile of
FT                                diacylglycerol utilization and results in
FT                                modest reduction in enzyme activity.
FT                                {ECO:0000269|PubMed:12221122}.
FT   MUTAGEN     215    215       E->A,D: Induces a strong reduction in
FT                                enzyme activity without altering
FT                                diacylglycerol specificity.
FT                                {ECO:0000269|PubMed:12221122}.
FT   MUTAGEN     215    215       E->Q: Induces a strong reduction in
FT                                enzyme activity and alters diacylglycerol
FT                                specificity.
FT                                {ECO:0000269|PubMed:12221122}.
FT   MUTAGEN     216    216       V->A: Alters the profile of
FT                                diacylglycerol utilization and results in
FT                                modest reduction in enzyme activity.
FT                                {ECO:0000269|PubMed:12221122}.
FT   MUTAGEN     221    221       I->A: Alters the profile of
FT                                diacylglycerol utilization and results in
FT                                modest reduction in enzyme activity.
FT                                {ECO:0000269|PubMed:12221122}.
FT   MUTAGEN     226    226       L->A: Does not affect either the enzyme
FT                                activity or the diacylglycerol
FT                                specificity.
FT                                {ECO:0000269|PubMed:12221122}.
FT   MUTAGEN     228    228       V->A: Does not affect either the enzyme
FT                                activity or the diacylglycerol
FT                                specificity.
FT                                {ECO:0000269|PubMed:12221122}.
SQ   SEQUENCE   416 AA;  46554 MW;  A25FED1193342FD9 CRC64;
     MSGHRSTRKR CGDSHPESPV GFGHMSTTGC VLNKLFQLPT PPLSRHQLKR LEEHRYQSAG
     RSLLEPLMQG YWEWLVRRVP SWIAPNLITI IGLSINICTT ILLVFYCPTA TEQAPLWAYI
     ACACGLFIYQ SLDAIDGKQA RRTNSSSPLG ELFDHGCDSL STVFVVLGTC IAVQLGTNPD
     WMFFCCFAGT FMFYCAHWQT YVSGTLRFGI IDVTEVQIFI IIMHLLAVIG GPPFWQSMIP
     VLNIQMKIFP ALCTVAGTIF SCTNYFRVIF TGGVGKNGST IAGTSVLSPF LHIGSVITLA
     AMIYKKSAVQ LFEKHPCLYI LTFGFVSAKI TNKLVVAHMT KSEMHLHDTA FIGPALLFLD
     QYFNSFIDEY IVLWIALVFS FFDLIRYCVS VCNQIASHLH IHVFRIKVST AHSNHH
//
